| 翻訳と辞書 |
| Christoph Westphal ： ウィキペディア英語版 |
Christoph Westphal
Christoph Westphal, M.D., Ph.D., co-founded Sirtris Pharmaceuticals in 2004 with David Sinclair and served as Chief Executive Officer until April 2010.〔(Sirtris Scientific Advisory Board )〕 Dr. Westphal also founded the Longwood Founders Fund 〔("Sirtris Founders Build New Venture Capital Fun, Keep Mum" Xconomy, February 12, 2010 )〕 and was previously the President of SR One, the corporate venture capital arm of GlaxoSmithKline (GSK).〔(SR One website - Team Bios )〕
==Current Position==
Westphal is currently the chair and CEO of Flex Pharma. Westphal was previously the President of SR One, which is a GSK venture capital firm that invests globally in emerging life science companies. Dr. Westphal is a Founder and General Partner of the Longwood Fund, a venture capital fund based in Boston.
Westphal currently serves on the Board of Directors of Flex Pharma (Nasdaq FLKS) and Verastem (Nasdaq VSTM), and the Board of Fellows of Harvard Medical School, the Board of Overseers of the Boston Symphony Orchestra, and the board of Biotechnology Innovation Organization (BIO). Westphal has been the lead or senior author on several patent applications and scientific papers in journals, including ''Cell, Nature and Nature Genetics''.〔(Sirtris publications )〕 l
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Christoph Westphal」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|